Results 191 to 200 of about 5,561 (244)

Elimination of Cholesterol as Bile Acids in Hyperlipoproteinemias Type II and IV [PDF]

, 1974
Several studies indicate that cholesterol metabolism is regulated differently in hyperlipoproteinaemia type II and type IV (cf. Miettinen, 1973). Data on the turn-over of the two bile acids synthesized in the liver (cholic acid and chenodeoxycholic acid) show that the formation of bile acids in patients with a type II lipoprotein pattern is lower than ...
Mora Kallner, Kjell Hellström, Kurt Einarsson   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pediatric Familial Type II Hyperlipoproteinemia: Therapy With Diet and Colestipol Resin

Pediatrics, 1976
Effects of a low-cholesterol, polyunsaturate rich diet and a synthetic organic bile sequestrant polymer (U26,597A, colestipol) were studied in 21 children, heterozygous for familial hypercholesterolemia. Total cholesterol, β-lipoprotein cholesterol, and triglyceride were measured twice on habitual diet, monthly for six months on a low-cholesterol diet,
C J, Glueck, R W, Fallat, M, Mellies, R C, Tsang   +3 more
openaire   +2 more sources

Effect of Acipimox on serum lipids and apoproteins in type II hyperlipoproteinemia

1987
Acipimox is a nicotinic acid derivative which has a potent triglyceride (TG) lowering effect induced by sustained inhibition of adipose tissue lipolysis (Fuccella et al., 1980; Sirtori et al. 1981; Stirling et al., 1985). The reduced free fatty acid flux to the liver, and the consequent reduction of the precursor pool of very low density lipoprotein ...
M. Lavezzari, A. M. Mogavero, M. Di Tommaso, R. Taverniti, G. Siciliani, S. Palmisano, Francesco Resta, A. Capurso, D. Ciancia   +8 more
openaire   +2 more sources

Coronary Artery Disease Risk in Familial Type II Hyperlipoproteinemia

1974
Prospective and retrospective analyses of coronary artery disease (CAD) risk for affected and non-affected members of kindred with familial hypercholesterolemia, (Type II hyperlipoproteinemia), vary considerably. Slack found that by age 60, the risk of CAD and CAD death in first degree male relatives of Type II propositi was 85.4% and 54.1 ...
Robert I. Levy, Donald S. Fredrickson, Joel Verter, Neil J. Stone   +3 more
openaire   +2 more sources

Effect of pravastatin sodium on hemorheology in type II hyperlipoproteinemia [PDF]

Atherosclerosis, 1994
K. Satoh, Yoshiyasu Tsuda, Naohisa Hosomi, Tsutomu Takahashi, Yoshinari Izumi, Hitoshi Matsuo, Shin-Ichiro Ichihara   +6 more
openaire   +1 more source

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series

Rational Pharmacotherapy in Cardiology, 2023
V K Zafiraki, A M Namitokov, O V Malyarevskaya   +2 more
exaly  

Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic

European Journal of Clinical Investigation, 2020
José Rioja, Daiana Ibarretxe, Pedro Valdivielso   +2 more
exaly  

Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)

Archives of Medical Science, 2020
Vincent A Pallazola, Eliseo Guallar, Maciej Banach   +2 more
exaly  

The Intraerythrocytic Concentration of 2,3‐Diphosphoglycerate in Type II A Hyperlipoproteinemia

Acta Physiologica Scandinavica, 1977
J. Viikari, A. Lehtonen, A. Kari
openaire   +3 more sources

A case of pseudohomozygous type II hyperlipoproteinemia in early infancy

Pediatrics International, 2011
Tadashi Asami, Hiroshi Wakiguchi, Hideo Morita, Wataru Tamaki, Takatoshi Hosokawa, Mikiya Fujieda, Masato Maeda   +6 more
openaire   +3 more sources